A wide range of cough drops sold under different brand names has been suddenly pulled from shelves after health officials found problems at a factory in China. The U. S. Food and Drug Administration spotted issues during a routine inspection back in August 2025, but hasn’t explained exactly what wen
The U. S. Food and Drug Administration is preparing to review whether certain peptides—short chains of amino acids often hyped as quick-fix health boosters—should face fewer restrictions. These substances, popular in wellness circles and among some celebrities, have never undergone rigorous testing
The Food and Drug Administration announced a July meeting to review whether six or more unapproved peptide injections should move from a restricted drug category. These small protein fragments, popular with fitness influencers and some celebrities, promise quick muscle gains, injury healing or anti‑
Dog owners in the U. S. might soon have a new tool to help their aging pets live healthier, longer lives. A California-based company is testing a drug called LOY-002, designed to slow down aging in dogs. Unlike typical medications that treat specific diseases like arthritis or cancer, this pill aims
A new link between sleep-tracking gadgets and birth control apps is making waves. High-end fitness watches from a major brand now share nightly skin temperature data with a fertility app approved by health regulators. The idea is simple: cooler skin at night can hint at ovulation timing, helping use
The FDA has introduced a new program that promises super-fast drug approvals. This program, called the Commissioner’s National Priority Voucher, can approve drugs in just one to two months. This is much faster than the usual 10-month review process. The idea is to prioritize drugs that match certain
The FDA plans to give money to reviewers who finish ahead of time. Commissioner Makary explained the idea in a staff meeting last week. He called it a pilot program and said the first bonuses could start in August. The goal is to reward “weighted time savings” while keeping quality high. O
A leading health news site has earned a top journalism prize for its coverage of the changes in federal health policy under the last U. S. president. The award highlighted stories that traced how the Food and Drug Administration was reshaped, how scientific research funding shifted, and what these m
A recall has been issued for a specific batch of "Tippy Toes" baby food. The reason? Elevated levels of patulin, a substance produced by molds that can grow on fruits like apples. This recall is a precautionary measure, as long-term exposure to patulin can potentially cause health issues, including
Encora Therapeutics has earned FDA approval for its wrist‑sized device, the Encora X1, which can be prescribed to adults who suffer from essential tremor. The clearance means the product can now be sold in the United States for this specific use. Clinical data from two trials support the decision.
